{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:35:24Z","timestamp":1780349724550,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009086","name":"Medical University Sofia","doi-asserted-by":"publisher","award":["d-140\/24.06.2020"],"award-info":[{"award-number":["d-140\/24.06.2020"]}],"id":[{"id":"10.13039\/100009086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009086","name":"Medical University Sofia","doi-asserted-by":"publisher","award":["-140\/24.06.2020"],"award-info":[{"award-number":["-140\/24.06.2020"]}],"id":[{"id":"10.13039\/100009086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"EFSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jacl.2025.06.021","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:38:20Z","timestamp":1751427500000},"page":"1408-1415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-chain and very long-chain ceramide levels in subjects with impaired glucose regulation"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-4344","authenticated-orcid":false,"given":"Rumyana","family":"Dimova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-4133","authenticated-orcid":false,"given":"Vesela","family":"Lozanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevena","family":"Chakarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Serdarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Kirilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-3714","authenticated-orcid":false,"given":"Valentin","family":"Lozanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsvetalina","family":"Tankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.06.021_bib0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.106.685628","article-title":"Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)","volume":"116","author":"Barr","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.06.021_bib0002","doi-asserted-by":"crossref","first-page":"111589","DOI":"10.1016\/j.diabres.2024.111589","article-title":"International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes","volume":"209","author":"Bergman","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacl.2025.06.021_bib0003","article-title":"Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function and insulin sensitivity: pilot study from a real world health care setting","author":"Jagannathan","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.jacl.2025.06.021_bib0004","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2015-2573","article-title":"One-hour post-load hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose","author":"Fiorentino","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"10.1016\/j.jacl.2025.06.021_bib0005","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/dc12-1861","article-title":"One-hour glucose during an oral glucose challenge prospectively predicts beta-cell deterioration and prediabetes in obese Hispanic youth","volume":"36","author":"Kim","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.021_bib0006","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/cen.13280","article-title":"One-hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12-year community-based cohort study","volume":"86","author":"Oh","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.jacl.2025.06.021_bib0007","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc08-0225","article-title":"One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes","volume":"31","author":"Abdul-Ghani","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2025.06.021_bib0008","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc06-1331","article-title":"What is the best predictor of future type 2 diabetes?","volume":"30","author":"MA","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2025.06.021_bib0009","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2009.04.006","article-title":"Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis","volume":"207","author":"Succurro","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.06.021_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2016.11.020","article-title":"Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile","volume":"256","author":"Andreozzi","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.06.021_bib0011","article-title":"Cardiovascular and metabolic risk enhanced predictive capability of a 1-hour oral glucose tolerance test: a prospective population-based cohort study","author":"Pareek","year":"2017","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jacl.2025.06.021_bib0012","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/diacare.27.6.1496","article-title":"Lipids and lipoproteins in patients with type 2 diabetes","volume":"27","author":"Krauss","year":"2004","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.021_bib0013","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","article-title":"Pathophysiology of diabetic dyslipidaemia: where are we?","volume":"58","author":"Verg\u00e8s","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2025.06.021_bib0014","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/omi.2016.0178","article-title":"Novel lipidomic biomarkers in hyperlipidemia and cardiovascular diseases: an integrative biology analysis","volume":"21","author":"Rai","year":"2017","journal-title":"OMICS"},{"key":"10.1016\/j.jacl.2025.06.021_bib0015","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMra1104901","article-title":"The human plasma lipidome","volume":"365","author":"Quehenberger","year":"2011","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.021_bib0016","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbalip.2005.05.004","article-title":"The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis","volume":"1735","author":"Li","year":"2005","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Cell Biol Lipids"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.021_bib0017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1074\/jbc.M113.522847","article-title":"Ceramides and glucosylceramides are independent antagonists of insulin signaling","volume":"289","author":"havez","year":"2014","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.021_bib0018","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI43378","article-title":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice","volume":"121","author":"Holland","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jacl.2025.06.021_bib0019","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1007\/s00125-007-0781-2","article-title":"Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes","volume":"50","author":"Straczkowski","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2025.06.021_bib0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2025.06.021_bib0021","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1161\/ATVBAHA.111.234096","article-title":"Plasma lipidomic analysis of stable and unstable coronary artery disease","volume":"31","author":"Meikle","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Supplement 1","key":"10.1016\/j.jacl.2025.06.021_bib0022","first-page":"S13","article-title":"Standards of medical care in diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2025.06.021_bib0023","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1464-5491.1994.tb00273.x","article-title":"Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion","volume":"11","author":"Phillips","year":"1994","journal-title":"Diabetic Medicine"},{"issue":"8","key":"10.1016\/j.jacl.2025.06.021_bib0024","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/oby.2008.307","article-title":"Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test","volume":"16","author":"Retnakaran","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"10.1016\/j.jacl.2025.06.021_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2025.06.021_bib0026","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jacl.2025.06.021_bib0027","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","article-title":"Ceramides in insulin resistance and lipotoxicity","volume":"45","author":"Summers","year":"2006","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jacl.2025.06.021_bib0028","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1517\/14728222.2011.588209","article-title":"Ceramide formation as a target in beta-cell survival and function","volume":"15","author":"Lang","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jacl.2025.06.021_bib0029","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1210\/jc.2006-2347","article-title":"Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects","volume":"92","author":"Serlie","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2025.06.021_bib0030","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma ceramides: a novel predictor of major adverse cardiovascular events after coronary angiography","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.021_bib0031","doi-asserted-by":"crossref","first-page":"e5656","DOI":"10.1371\/journal.pone.0005656","article-title":"Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study\u2013secondary analysis of the randomized trial","volume":"4","author":"Uusitupa","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jacl.2025.06.021_bib0032","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbalip.2013.08.019","article-title":"Ceramide synthases as potential targets for therapeutic intervention in human diseases","volume":"1841","author":"Park","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.jacl.2025.06.021_bib0033","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2025.06.021_bib0034","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12944-022-01634-w","article-title":"Insulin resistance induced by de novo pathway\u2013generated C16-ceramide is associated with type 2 diabetes in an obese population","volume":"21","author":"Chathoth","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.021_bib0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cmet.2014.10.017","article-title":"C16:0-ceramide signals insulin resistance","volume":"20","author":"Hla","year":"2014","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.021_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107734","article-title":"Role of ceramides in the pathogenesis of diabetes mellitus and its complications","volume":"35","author":"Mandal","year":"2020","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jacl.2025.06.021_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.622692","article-title":"Rotten to the cortex: ceramide-mediated lipotoxicity in diabetic kidney disease","volume":"11","author":"Nicholson","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 14","key":"10.1016\/j.jacl.2025.06.021_bib0038","first-page":"002","article-title":"Targeted lipidomic and transcriptomic analysis identifies dysregulated renal ceramide metabolism in a mouse model of diabetic kidney disease","volume":"8","author":"Sas","year":"2015","journal-title":"J. Proteom. Bioinform."},{"issue":"3","key":"10.1016\/j.jacl.2025.06.021_bib0039","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ekir.2016.12.003","article-title":"Profiling of plasma metabolites suggests altered mitochondrial fuel usage and remodeling of sphingolipid metabolism in individuals with type 2 diabetes and kidney disease","volume":"2","author":"Liu","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jacl.2025.06.021_bib0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biochi.2013.07.027","article-title":"Ceramide and the mitochondrial respiratory chain","volume":"100","author":"Kogot-Levin","year":"2014","journal-title":"Biochimie"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:10:04Z","timestamp":1766157004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425003332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1933287425003332"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.021","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-chain and very long-chain ceramide levels in subjects with impaired glucose regulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}